| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a76c298aeac4048ee73b5164d43bbc53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
| filingDate |
2021-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89383076cd869a6b9fbbb62f7fc00ebf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d9a192e9124a0e8dd1be14529713dd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cca005a80dea46203f5c5cdc4f06710
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7f291f239039879f1c0eb67952d9374 |
| publicationDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021100937-A |
| titleOfInvention |
CNP prodrug with large carrier portion |
| abstract |
PROBLEM TO BE SOLVED: To provide a CNP prodrug or a pharmaceutically acceptable salt thereof. A carrier moiety-Z (reversible prodrug linker moiety-L 1- is covalently and reversibly bound to a CNP moiety-D; and a reversible prodrug linker moiety-L 1 −. A CNP prodrug containing −D) or a pharmaceutically acceptable salt thereof [−L 2 − is a chemical bond or spacer; −Z is a polymer having a molecular weight of at least 10 kDa. ]. The present invention further relates to pharmaceutical compositions containing CNP prodrugs or pharmaceutically acceptable salts thereof, their medicinal use, and methods of treatment. [Selection diagram] Fig. 1 |
| priorityDate |
2016-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |